CHRU de Brest - Hôpital Morvan

The trials here

What the 8 trials at this site are about, from their registry records.

Conditions

• Myeloproliferative neoplasms2 trials
• Atopic dermatitis (eczema)1 trial
• Cervical cancer1 trial
• Duchenne muscular dystrophy1 trial
• Head and neck cancer1 trial
• Pancreatic cancer1 trial
• Prostate cancer1 trial

Phase

• Phase 33 trials
• Phase 1/21 trial
• Phase 21 trial

Status

• Completed5 trials
• Terminated2 trials
• Active, not recruiting1 trial

Lead sponsor

• University Hospital, Brest2 trials
• Eli Lilly and Company1 trial
• EMD Serono Research & Development Institute, Inc.1 trial
• Galera Therapeutics, Inc.1 trial
• Institut Cancerologie de l'Ouest1 trial
• and 2 more

Running trials

• Active, not recruiting

  Relapse in Previously Irradiated Prostate Bed : Stereotactic Ablative Reirradiation Potentiated by Metformin

  NCT04536805· Phase 1/2· Institut Cancerologie de l'Ouest· Source

Closed trials

• Terminated

  Phase 2b Study of GC4711 in Combination With SBRT for Nonmetastatic Pancreatic Cancer

  NCT04698915· Phase 2· Galera Therapeutics, Inc.· Source

• Terminated

  A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX)

  NCT04459715· Phase 3· EMD Serono Research & Development Institute, Inc.· Source

• Completed

  Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)

  NCT04392154· Phase 3· Eli Lilly and Company· Source

• Completed

  Interest of PET/CT at 18F-FDG in the Post-therapeutic Management of Cervical Cancer

  NCT04008095· University Hospital, Brest· Source

• Completed

  Pilot Study for the Development of a Diagnostic Score to Differentiate Myeloproliferative Neoplasms.

  NCT03869476· University Hospital, Angers· Source

• Completed

  Aprepitant Versus Hydroxyzine in Persistent Aquagenic Pruritus for Patients With Myeloproliferative Neoplasms

  NCT03808805· Phase 3· University Hospital, Brest· Source

• Completed

  Registry of Translarna (Ataluren) in Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)

  NCT02369731· PTC Therapeutics· Source